bpc-157 effectiveness clinical studies Peptide Therapy for Pain Management and Healing BPC-157 vs TB-500: Complete Comparison
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 273
The peptide does not suddenly become useless at day 28, but potency gradually decreases after reconstitution
Kennedy has been candid about the tradeoff
To learn more, visit functionhealth.comhuberman and use the code huberman for a $50 credit towards your membership
As of May 2026, BPC-157 remains on the FDAs Category 2 restricted list, pending advisory-committee review
What to Do If You See Air Bubbles Small air bubbles in a subcutaneous injection are harmless unlike IV injections, they won't cause any issues
